<DOC>
	<DOCNO>NCT01762826</DOCNO>
	<brief_summary>Comparison different inositol stereoisomears prevent adverse obstetric outcome non-obese pregnant woman high risk gestational diabetes mellitus .</brief_summary>
	<brief_title>Myo-inositol , D-chiro-inositol , D-chiro/Myo-inositol Gestational Diabetes</brief_title>
	<detailed_description>The investigator compare outcomes metabolic obstetric point view GDM pregnant non-obese patient different stereoisomears inositol supply . Dietary control placebo inositol steroisomears administer start enrol time ( first fast oral glucose 92 mg % ; usually 20 week gestation ' ) till delivery and/or pregnancy end/termination . Oral glucose tolerance test result 24-28 week ' gestation evaluate ( glucose value oGTT screen ) . Fetal growth , delivery data , obstetric outcome necessity insulin therapy take account .</detailed_description>
	<mesh_term>Diabetes , Gestational</mesh_term>
	<mesh_term>Inositol</mesh_term>
	<mesh_term>Folic Acid</mesh_term>
	<criteria>pregnancy 20 week gestation BMI 30 Fasting glucose 92 126 mg % Singleton pregnancy Naturally conceive obese patient Fasti g glucose 126 92</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>45 Years</maximum_age>
	<verification_date>September 2012</verification_date>
	<keyword>Inositol</keyword>
	<keyword>GDM</keyword>
</DOC>